Cargando…
Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer
BACKGROUND: Body mass index (BMI) is largely investigated as a prognostic and predictive factor in triple-negative breast cancer (TNBC). Overweight and obesity are linked to a variety of pathways regulating tumor-promoting functions, including the DNA damage response (DDR). The DDR physiologically s...
Autores principales: | Barba, Maddalena, Vici, Patrizia, Pizzuti, Laura, Di Lauro, Luigi, Sergi, Domenico, Di Benedetto, Anna, Ercolani, Cristiana, Sperati, Francesca, Terrenato, Irene, Botti, Claudio, Mentuccia, Lucia, Iezzi, Laura, Gamucci, Teresa, Natoli, Clara, Vitale, Ilio, Mottolese, Marcella, De Maria, Ruggero, Maugeri-Saccà, Marcello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294880/ https://www.ncbi.nlm.nih.gov/pubmed/28166748 http://dx.doi.org/10.1186/s12885-016-3045-z |
Ejemplares similares
-
Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis
por: Vici, Patrizia, et al.
Publicado: (2015) -
Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy
por: Vici, Patrizia, et al.
Publicado: (2016) -
Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression
por: Di Benedetto, Anna, et al.
Publicado: (2017) -
The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy
por: Vici, Patrizia, et al.
Publicado: (2014) -
The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer
por: Benedetto, Anna Di, et al.
Publicado: (2016)